01054
Study Phase Evaluability
2003-08-22
Definition: This field contains the disposition of the patient_s data for this phase interval for quality control and data analysis purposes. The set of codes will vary across clinical trials. An example answer set: Complete, Adverse Events Only, Outcome Only, None, Unknown.
Length≤250
6 components
| 1 | O | - | Identifier | |
| 2 | O | - | Text | |
| 3 | O | Name of Coding System | ||
| 4 | O | - | Alternate Identifier | |
| 5 | O | - | Alternate Text | |
| 6 | O | Name of Alternate Coding System |